79307220
Dec 11, 2020
pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections or diseases caused by viruses; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections or diseases caused by viruses, namely, by intravenous, intramuscular, oral, sublingual, buccal, nasal, topical administration and/or administered by inhalation, by spraying or by nebulisation in patients; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections caused by viruses, seasonal and pandemic influenza A and B viruses, seasonal coronaviruses being Alpha-, Beta-, Gamma- and Deltacoronaviruses, severe acute respiratory syndrome (SARS-CoV) coronaviruses and Middle East respiratory syndrome (MERS) coronavirus, adenoviruses, respiratory syncytial viruses, parainfluenza viruses, rhinoviruses, human metapneumoviruses, bocaviruses, and infections of combined etiology being multiple viral infections; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections caused by viral infections of the upper and lower respiratory tract; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of acute respiratory infections caused by viral infections of the upper and lower respiratory tract; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of tissue lesions in the lungs caused by severe pulmonary infectious diseases; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of complications arising from or caused by viral infections; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of acute respiratory infections, acute respiratory viral infections of unknown origins and complications arising from or caused by viral infections
Pharmaceuticals